Crossing Over: Drug Network Characteristics and Injection Risk Along the China–Myanmar Border
- 178 Downloads
Border areas are important locations for understanding HIV transmission. This study examines individual and network correlates of border crossing and equipment sharing among methadone maintenance clients in Ruili City, a Chinese city on the Myanmar border. Data are from 298 clients enrolled in the Ruili Methadone Treatment Center. Clients were interviewed about drug use, HIV/AIDS knowledge, treatment motivation, and their social networks. Multinomial and logistic regression analysis were performed. Thirty percent of clients reported injecting in Myanmar. Compared to drug networks that usually inject in China, networks that inject equally in both places (border crossing) are more likely to share equipment. The association between HIV positive status and border-crossing was marginally significant and robust. Results indicate some added degree of risk among clients and drug networks who border-cross to use drugs. More research is needed to understand this phenomenon.
KeywordsBorder Injection risk behavior Drug networks China Drug treatment
This study was conducted through a dissertation award to W. Liu by the AIDS International Training and Research Program at UIC through funding from the Fogarty International Center, NIH (D43TW001419-09). The Ruili CDC under the leadership of Dr. Li Zhoulin and the Mayor’s office of the City of Ruili also contributed support.
- 1.UNAIDS. AIDS Epidemic Update 2009: Asia fact sheet. Geneva: Joint United Nations Programme on HIV/AIDS; 2009.Google Scholar
- 4.UNESCO. HIV/AIDS in the GMS: a cross-border problem. Bulletin for prevention education in the greater Mekong subregion, Issue 1, 1–3. Thailand: HIV/AIDS Clearing House of the UNESCO Asia and Pacific Regional Bureau for Education; 2004.Google Scholar
- 5.du Guerny J, Hsu L-N, Hong C. Population movement and HIV/AIDS: the case of Ruili, Yunnan, China. UNDP Southeast Asia HIV and Development Programme; August 2003Google Scholar
- 12.Ministry of Health, P. R. China and UN Theme Group on HIV/AIDS in China. China responds to AIDS: HIV/AIDS situation and needs assessment report. Beijing: Chinese Ministry of Health, November 1997.Google Scholar
- 15.Chantavanich S. Preventing HIV/AIDS among mobile populations in the greater Mekong subregion, Asian Development Bank, the United Nations Development Program; 2000.Google Scholar
- 22.Hammett TM, Kling R, Johnston P, Liu W, Ngu D, Friedmann P, et al. Patterns of HIV prevalence and HIV risk behaviors among injection drug users prior to and 24 months following implementation of cross-border HIV prevention interventions in northern Vietnam and southern China. AIDS Educ Prev. 2006;18(2):97–115.PubMedCrossRefGoogle Scholar
- 23.Bergenstrom A, Htoon YS, Sharma M, Garg R, Macdonald V, Awng H, Buhler M, Gang S. Myanmar country advocacy brief injecting drug use and HIV. A joint publication by United Nations Regional Task Force on injecting drug use and HIV/AIDS for Asia and the Pacific and HIV/AIDS Asia Regional Program, 2010.Google Scholar
- 26.Williams CT, Metzger D. Race and distance effects on regular syringe exchange program use and other injection risks: a geo-behavioral analysis. Am J Public Health. (in press)Google Scholar
- 29.Loftus E, Smith K, Klinger M, Fiedler J. Memory and mismemory for health events. In: Tanur JM, editor. Questions about questions: Inquiries into the cognitive bases of surveys. New York: Russell Sage Foundation; 1991. p. 102–37.Google Scholar